LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Summit Therapeutics (NASDAQ: SMMT)

Follow NASDAQ:SMMT Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SMMT Summit Therapeutics
Zanganeh Mahkam / director, 10 percent owner, officer: Co-Chief Executive Officer
04/08/2025
Buy
$1.58
3.99M
$6.296M
555.68M
NASDAQ SMMT Summit Therapeutics
Zanganeh Mahkam / director, 10 percent owner, officer: Co-Chief Executive Officer
04/08/2025
Buy
$1.58
3.99M
$6.296M
0
NASDAQ SMMT Summit Therapeutics
DUGGAN ROBERT W / director, 10 percent owner, officer: Co-Chief Executive Officer
04/08/2025
Buy
$1.58
3.99M
$6.296M
555.68M
NASDAQ SMMT Summit Therapeutics
DUGGAN ROBERT W / director, 10 percent owner, officer: Co-Chief Executive Officer
04/08/2025
Buy
$1.58
3.99M
$6.296M
0

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous